Literature DB >> 8376547

Differential effects of prolactin upon activation and differentiation of human B lymphocytes.

N Lahat1, A Miller, R Shtiller, E Touby.   

Abstract

The effects of human prolactin on enriched peripheral B lymphocytes obtained from healthy males were examined. Immunoregulation by prolactin was studied in B cells activated with either anti-IgM alone, or anti-IgM antibodies and recombinant interleukin-2 (r-IL-2), as well as control resting B cells. Expression of IL-2 receptors (IL-2R), and IgM and IgG in the culture supernatants were used as a measure of B cell activation and differentiation. Prolactin significantly synergized with IL-2 in the enhancement of surface expression of IL-2R on anti-IgM treated B cells. Although no differentiating effect was observed on resting B cells, prolactin (0.2-100 ng/ml) exhibited a dose-dependent enhancement upon both IgM and IgG secretion from B cells treated with anti-IgM and IL-2. In the absence of exogenously added IL-2 similar differentiating effect were observed in B cells treated with anti-IgM at prolactin concentrations of 0.2-10 ng/ml, but not 100 ng/ml. Thus, the present results demonstrate the modulatory effect of prolactin on activation and differentiation of anti-IgM triggered human B cells, and emphasize the importance of co-stimulatory signal mediated by IL-2 in B cell responses to high prolactin levels. These findings extend the immunoregulatory effects of prolactin, previously confirmed for T cells, to the B cell arm of the immune response, and suggest an important role of prolactin in mediating adaptation and communication between the nerve and immune systems.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376547     DOI: 10.1016/0165-5728(93)90282-4

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

1.  Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients.

Authors:  Hedi Orbach; Gisele Zandman-Goddard; Mona Boaz; Nancy Agmon-Levin; Howard Amital; Zoltan Szekanecz; Gabriella Szucs; Josef Rovensky; Emese Kiss; Andrea Doria; Anna Ghirardello; Jesus Gomez-Arbesu; Ljudmila Stojanovich; Francesca Ingegnoli; Pier Luigi Meroni; Blaz' Rozman; Miri Blank; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

2.  Prolactin has a pathogenic role in systemic lupus erythematosus.

Authors:  Luis J Jara; Gabriela Medina; Miguel A Saavedra; Olga Vera-Lastra; Honorio Torres-Aguilar; Carmen Navarro; Monica Vazquez Del Mercado; Luis R Espinoza
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

3.  Prolactin enhances the in vitro production of IgG in peripheral blood mononuclear cells from patients with systemic lupus erythematosus but not from healthy controls.

Authors:  A M Jacobi; W Rohde; H D Volk; T Dörner; G R Burmester; F Hiepe
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

4.  Prolactin may not play a role in primary antiphospholipid (Hughes') syndrome.

Authors:  Manoel Tavares Neves Junior; Carlos Ewerton Maia Rodrigues; Jozelio Freire de Carvalho
Journal:  Clin Dev Immunol       Date:  2011-04-07

5.  Multiple cAMP-induced signaling cascades regulate prolactin expression in T cells.

Authors:  S Gerlo; P Verdood; E L Hooghe-Peters; R Kooijman
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

6.  Acquired prolactin deficiency in patients with disorders of the hypothalamic-pituitary axis.

Authors:  Y Toledano; A Lubetsky; I Shimon
Journal:  J Endocrinol Invest       Date:  2007-04       Impact factor: 4.256

7.  A sustained high fat diet for two years decreases IgM and IL-1 beta in ageing Wistar rats.

Authors:  Georg Pongratz; Torsten Lowin; Robert Kob; Roland Buettner; Thomas Bertsch; L Cornelius Bollheimer
Journal:  Immun Ageing       Date:  2015-09-28       Impact factor: 6.400

8.  Dysregulation of In Vitro Decidualization of Human Endometrial Stromal Cells by Insulin via Transcriptional Inhibition of Forkhead Box Protein O1.

Authors:  Dorina Ujvari; Ivika Jakson; Shabnam Babayeva; Daniel Salamon; Bence Rethi; Sebastian Gidlöf; Angelica Lindén Hirschberg
Journal:  PLoS One       Date:  2017-01-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.